J.P. Morgan Reaffirms Buy Rating for Shell (UK) with £30.00 Price Target

J.P. Morgan analyst Matthew Lofting maintains a Buy rating on Shell (UK) with a £30.00 price target. The analyst has a 50.50% success rate and an average return of -1.9%. The company has a Moderate Buy consensus with a £3,035.98 price target, implying an 11.80% upside. Shell (UK) has a one-year high of £2,843.00 and a one-year low of £2,269.92.

Shell (UK) continues to receive positive analyst ratings, with J.P. Morgan analyst Matthew Lofting reaffirming his Buy recommendation, setting a £30.00 price target. The company's shares closed at £2,715.50 today, with a one-year high of £2,843.00 and a one-year low of £2,269.92 [2].

Lofting's recommendation comes amidst a general consensus of Moderate Buy for Shell (UK), with an average price target of £3,035.98, implying an 11.80% upside from current levels. RBC Capital's Biraj Borkhataria also maintains a Buy rating with a £34.00 target price, while other analysts, including TR | OpenAI – 4o, have reiterated their Buy ratings [1, 2].

Shell's latest earnings report for the quarter ending June 30 showed a quarterly revenue of £65.41 billion and a net profit of £3.6 billion, compared to last year's £74.46 billion in revenue and £3.52 billion in net profit. The company's quick ratio stands at 1.07, current ratio at 1.32, and debt-to-equity ratio at 0.36. The company has a market cap of £216.84 billion, a price-to-earnings ratio of 16.62, a PEG ratio of 1.94, and a beta of 0.44 [3].

Several large investors have increased their holdings in Shell, with Goldman Sachs Group Inc. raising its stake by 21.2% to over 6.5 million shares. Other notable investors, such as Harvest Portfolios Group Inc., Dimensional Fund Advisors LP, and Price T Rowe Associates Inc. MD, have also increased their stakes in the company [3].

Shell's recent dividend announcement of £0.716 per share, with an annualized yield of 3.9%, and the authorization of a share repurchase plan of £3.50 billion further support the company's financial health. The company's share repurchase plan allows it to buyback up to 1.8% of its stock through open market purchases, indicating that management believes its shares are undervalued [3].

References:
[1] https://www.marketscreener.com/news/shell-neu-jp-morgan-reaffirms-its-buy-rating-ce7c50dfdd88f021
[2] https://www.theglobeandmail.com/investing/markets/stocks/SHEL/pressreleases/34459727/rbc-capital-remains-a-buy-on-shell-uk-shel/
[3] https://www.marketbeat.com/instant-alerts/filing-shell-plc-unsponsored-adr-shel-shares-sold-by-harvest-portfolios-group-inc-2025-08-26/